Health and survival of young children in southern Tanzania. by Armstrong Schellenberg, Joanna RM et al.
Schellenberg, JR; Maokola, W; Shirima, K; Manzi, F; Mrisho, M;
Mushi, A; Alonso, P; Mshinda, H; Tanner, M; Schellenberg, DM
(2011) Cluster-randomized study of intermittent preventive treat-
ment for malaria in infants (IPTi) in southern Tanzania: evaluation
of impact on survival. Malar J, 10. p. 387. ISSN 1475-2875
Downloaded from: http://researchonline.lshtm.ac.uk/40323/
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: Creative Commons Attribution http://creativecommons.org/licenses/by/2.5/
RESEARCH Open Access
Cluster-randomized study of intermittent
preventive treatment for malaria in infants (IPTi)
in southern Tanzania: evaluation of impact on
survival
Joanna RM Armstrong Schellenberg1,2*, Werner Maokola2, Kizito Shirima2, Fatuma Manzi2, Mwifadhi Mrisho2,
Adiel Mushi2,3, Pedro Alonso4,5, Hassan Mshinda2, Marcel Tanner6,7 and David M Schellenberg1
Abstract
Background: Intermittent Preventive Treatment for malaria control in infants (IPTi) consists of the administration of
a treatment dose of an anti-malarial drug, usually sulphadoxine-pyrimethamine, at scheduled intervals, regardless of
the presence of Plasmodium falciparum infection. A pooled analysis of individually randomized trials reported that
IPTi reduced clinical episodes by 30%. This study evaluated the effect of IPTi on child survival in the context of a
five-district implementation project in southern Tanzania. [Trial registration: clinical trials.gov NCT00152204].
Methods: After baseline household and health facility surveys in 2004, five districts comprising 24 divisions were
randomly assigned either to receive IPTi (n = 12) or not (n = 12). Implementation started in March 2005, led by
routine health services with support from the research team. In 2007, a large household survey was undertaken to
assess the impact of IPTi on survival in infants aged two-11 months through birth history interviews with all
women aged 13-49 years. The analysis is based on an “intention-to-treat” ecological design, with survival outcomes
analysed according to the cluster in which the mothers lived.
Results: Survival in infants aged two-11 months was comparable in IPTi and comparison areas at baseline. In
intervention areas in 2007, 48% of children aged 12-23 months had documented evidence of receiving three doses
of IPTi, compared to 2% in comparison areas (P < 0.0001). Over the three years of the study there was a marked
improvement in survival in both groups. Between 2001-4 and 2005-7, mortality rates in two-11 month olds fell
from 34.1 to 23.6 per 1,000 person-years in intervention areas and from 32.3 to 20.7 in comparison areas. In 2007,
divisions implementing IPTi had a 14% (95% CI -12%, 49%) higher mortality rate in two-11 month olds in
comparison with non-implementing divisions (P = 0.31).
Conclusion: The lack of evidence of an effect of IPTi on survival could be a false negative result due to a lack of
power or imbalance of unmeasured confounders. Alternatively, there could be no mortality impact of IPTi due to
low coverage, late administration, drug resistance, decreased malaria transmission or improvements in vector
control and case management. This study raises important questions for programme evaluation design.
Background
Malaria control has benefited from substantial financial
investment and political commitment in the last decade,
and impressive progress is being made in some settings.
However, Plasmodium falciparum infection continues to
cause hundreds of millions of clinical episodes, and hun-
dreds of thousands of deaths every year. The greatest
burden of malaria deaths still falls on very young chil-
dren living in sub-Saharan Africa. IPTi involves the
delivery of sulphadoxine-pyrimethamine (SP) to children
when they receive routine vaccinations at about two,
three and nine months of age. A pooled analysis of six
randomized controlled trials reported that IPTi with SP
* Correspondence: Joanna.schellenberg@lshtm.ac.uk
1London School of Hygiene and Tropical Medicine, London, UK
Full list of author information is available at the end of the article
Schellenberg et al. Malaria Journal 2011, 10:387
http://www.malariajournal.com/content/10/1/387
© 2011 Schellenberg et al; licensee BioMed Central Ltd. This is an Open Acess article distributed under the terms of the Creative
Common Attribution License (http://creativecommons.org/license/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
can reduce clinical malaria episodes by 30%, decrease
anaemia by 21% and admissions to hospital by 23% [1].
The study involved development and implementation
of a strategy for IPTi in five remote, rural districts in
southern Tanzania in order to assess the feasibility,
acceptability, financial and economic costs of IPTi-SP
when deployed as part of routine, programme-based
activities within the given health system. The scale of the
operation also afforded an opportunity to consolidate the
safety profile of IPTi-SP. The project was conducted
under the auspices of the IPTi Consortium, a group of
research collaborations intent on generating an evidence
base to inform a policy decision on the use of IPTi. The
Consortium considered alternative approaches to evalu-
ate the impact on survival of IPTi. However, it would not
have been feasible to complete recruitment to an indivi-
dually randomized controlled survival trial before a policy
decision at the end of 2006. The best opportunity to esti-
mate an effect on mortality thus fell on this five-district
implementation study in southern Tanzania.
The aim of the project was to develop, implement and
evaluate a strategy for the routine deployment of IPTi
by the existing health services in Tanzania. Previous stu-
dies had evaluated the safety and efficacy of IPTi in rela-
tively small-scale, individually randomized trials, where
provision and administration of the intervention were
taken care of by the research teams. Whereas the IPTi
intervention is the delivery of SP to infants attending
vaccination clinics, a number of elements are required
in order to make IPTi available as a strategy integrated
within routine preventive health services for infants.
Mothers must be aware of IPTi and willing for their
children to accept the intervention; health workers must
accept and understand the intervention; IPTi needs to
be available alongside vaccinations in health facilities;
district council health management teams, who would
be responsible for the IPTi programme, must be
equipped with adequate and specific tools to manage
the requisition and supply of IPTi-related materials and
to train staff and raise community awareness. Going to
scale with IPTi would also depend on effective IPTi-spe-
cific management systems at regional and national
levels, and the longer-term availability and scaling-up
would need sound financing strategies. These elements
are prerequisites to high and sustainable coverage of
IPTi in rural communities within a systems approach
[2]. It is within this context that this study evaluated the
effect of IPTi on survival.
The development of the strategy for the IPTi interven-
tion, and specifically acceptability, and results on safety,
costs and community effectiveness for malaria parasitae-
mia, anaemia, and clinical episodes are presented else-
where [3-9]. This paper presents the evidence of the
impact of IPTi on survival in children aged two-11
months from a cluster-randomized trial in 243,000
households.
Methods
Overview
After baseline household and health facility surveys in
2004 [7], the research team developed a strategy for
IPTi implementation in partnership with the Ministry of
Health during 2004-2005 [4,6]. Twelve of 24 clusters
were randomly assigned to receive IPTi, and implemen-
tation started in March 2005 led by routine health ser-
vices with limited support from the research team. The
trial profile is shown in Figure 1. In 2006, a follow-up
health facility survey documented the availability of IPTi
and staff trained in its delivery, together with an interim
household survey to assess IPTi coverage and effects on
the prevalence of malaria and anaemia [8]. In 2007, a
large household survey which included the entire popu-
lation was undertaken to assess the impact of IPTi on
infant survival. The focus of this manuscript is the ana-
lysis of survival and includes process and contextual fac-
tors from household surveys to support that analysis.
An intention-to-treat approach and an ecological design
was used, with survival outcomes analysed according to
the cluster in which the mothers lived and being
unlinked to individual records of IPTi use.
Study area
The study area covers five districts, split into 24 admin-
istrative divisions, in the Lindi and Mtwara regions of
southern Tanzania. Lindi Rural, Ruangwa and Naching-
wea districts are in Lindi Region and Newala and Tan-
dahimba are in Mtwara region. The area has a total
population of over 800,000 people and the highest
reported infant mortality rates in the country [10,11].
Relatively neglected for many years, the infrastructure is
weak with poor access to water and electricity. Most
people are small-scale subsistence farmers although the
area produces most of Tanzania’s cashew nuts as a cash
crop through small-holder approaches.
At baseline in 2004 a representative sample of 21,482
households was identified using a modified EPI cluster
sampling strategy, as reported in detail elsewhere [7]. In
brief, 30 clusters of 30 households were identified in
each division. Where written informed consent was
given to interview, data were collected using Personal
Digital Assistants (PDAs), enhancing data quality and
timely availability of cleaned data [12] in anticipation of
randomization of divisions to intervention or compari-
son groups. Birth histories were done in 19,008 (94%) of
the 20,138 women aged 15-49 years reportedly resident
in the households. For eight clusters in each division,
additional information was collected on children aged
under 2 years old about illnesses in the preceding 2
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weeks, health-seeking behaviour and the prevalence of
anaemia and parasitaemia [7,8].
Randomization
The 24 divisions were arranged into three strata on the
basis of mortality in children aged two-11 months, as
measured in the baseline household surveys. Restricted
randomization was used to allocate each of the 24 divi-
sions into the IPTi or comparison group so as to assure
adequate balance in terms of baseline mortality, overall
population size and district health management team
[13]. Details are given elsewhere [8]. Briefly, of 343,000
possible ways of allocating 12 divisions to the interven-
tion arm (four within each of the three strata), 11,014
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Figure 1 Trial profile.
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achieved “balance” with respect to mortality, population
size and district, and one of these was chosen at
random.
Implementation of the IPTi strategy
A detailed description of the development and imple-
mentation of the IPTi strategy is given elsewhere [4].
Following development of the IPTi strategy and piloting
in two health facilities for a month, staff working in dis-
trict and regional health teams trained front-line health
workers how to implement IPTi in the first quarter of
2005. Subsequent follow-up by the project was limited
to a single IPTi-specific health facility visit after training,
followed by occasional visits to health facilities when the
district health teams undertook routine supervision vis-
its. All visits to health facilities were made in conjunc-
tion with members of the district health team. The
IPTi-specific “follow-up after training” visits to each
facility were completed before 24 May 2005: therefore,
24 May 2005 is used as the start date of the
intervention.
Monitoring of acceptability, financial and economic
costs, the impact on morbidity and the safety of IPTi
was established and is reported elsewhere. Four in vivo
anti-malarial drug efficacy tests were conducted (one in
2005 and three in 2006), following the standard WHO
protocol with 42 days of follow-up. These studies
showed 28 day PCR uncorrected adequate parasitologi-
cal and clinical response rates of 62-63% in three sites
and 49% in one site (data not shown), compared with
60% previously documented in the context of an earlier
clinical trial which showed IPTi to be highly efficacious
[14]. Molecular analysis of samples collected in house-
hold surveys showed a 44% frequency of the DHFR tri-
ple mutation in 2004, rising to 60% in 2007. The
frequency of the 540E mutation (a marker of the quin-
tuple mutation, DHFR triple and DHPS double) was
65% in 2004, 80% in 2006 and 68% in 2007 [unpublished
observations].
Surveys in 2006, after a year’s implementation of the IPTi
strategy
Health facility and household surveys in 2006 showed
that IPTi was available in 94% of intended health facil-
ities and that there was evidence of a biological effect
on malaria and anaemia in the target group of children
aged two-11 months [8].
2007 household surveys
The primary aim of this final household survey was to
estimate the effect of the IPTi strategy on mortality in
children aged two-11 months. Secondary aims included
(i) estimation of the coverage of IPTi in a sub-sample of
households, and (ii) to assess whether there were any
large imbalances between the IPTi and comparison
groups in contextual factors including preventive health
measures such as mosquito nets and vaccine coverage,
nutritional status, case management and care-seeking
for recent illness. Such factors were potential confoun-
ders of the effect of the IPTi strategy on infant survival.
Sample size
Mortality (main survey, all households)
The aim was to include all households in the area, with
an expected total of roughly 250,000 and a range from
2,500 to 26,000 households in any one division. On the
basis of the baseline survey in 2004, a two-11 month
mortality rate of 36.2 per 1,000 person-years was
expected, or approximately 463 deaths, in the compari-
son group, providing 80% power to detect an impact of
IPTi of 30% on survival, equivalent to a reduction from
36 to 25 deaths per 1,000 child years [13].
Coverage (sub-sample of households)
In a clustered subsample of households this sub-study
aimed to estimate coverage of IPTi of 50% to within 5%
points, assuming a 95% confidence level, that 3.14% of
the population is in this age group, an average of 100
households in each cluster, 3.88 people per household,
and a design effect of two. Eight sub-villages (vitongoji)
were selected from each division with equal probability
and more children from larger vitongoji, thus assuring
the sample of children was self-weighting within each
division.
Field methods-main survey
Overview
Between 25 June and 30 October 2007, the main survey
teams visited all households in the five districts and
completed a household module. Women aged 13-49
years had a birth history module completed. Mothers of
children < 2 years were asked if they were willing to be
visited by the child health survey team. A random sam-
ple of those who were willing was selected and visited
by these teams after the initial survey (see child health
survey, below).
Survey tools
The household module included identifiers, household
assets (socio-economic status markers), education and
occupation of the household head, listing of all members
of the household, and location of the household using a
GPS. The birth history module, for women age 13-49
years, documented live births in the previous five years,
whether the child was still alive, and dates of all events.
For all live births in the 1 year before the survey, further
questions related to use of antenatal clinics (ANC), mos-
quito nets, and IPT in the most recent pregnancy, place
of childbirth, attendant, and essential newborn care indi-
cators, for the most recent birth.
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Community sensitization and preparation
A series of feedback and sensitization meetings was held
in Mtwara and Lindi regions in March and April 2007.
The aims were (1) to sensitize the ward councillors,
ward executive officers and divisional secretaries about
the survey and to seek their assistance in identifying
candidates for training as field interviewers, and (2) to
update the list of all sub-villages (vitongoji) and obtain
estimates of the numbers of households in each sub-vil-
lage. Widespread support for the project team was evi-
denced by the assistance of local civil administrators in
developing a master list of 2,766 sub-villages comprising
more than 250,000 households. This list was used to
plan the logistics of interviewer training and the survey
itself.
Pre-piloting
Two rounds of pre-piloting were done in a district adja-
cent to the project area in order to prepare a core team
for the main survey training and to explore the feasibil-
ity of alternative approaches to the main survey, includ-
ing estimates of the number of people to be interviewed
per day, assessing the robustness of survey tools, devel-
opment of Standard Operating Procedures for house-
hold listing, mapping and interviewing, etc. The survey
tools built on experience with previous surveys in south-
ern Tanzania which themselves had drawn heavily on
standard MICS, DHS and malaria indicator surveys. The
survey tools were developed into PDA-based question-
naires that were pilot tested and validated separately.
Training
The piloting activities were followed by a 1 week pre-
training session for 14 facilitators. This ensured that a
group of experienced interviewers was then available to
support the main training, allowed further pre-testing of
the PDA-based questionnaires and supported prepara-
tions for the organization of the bigger group.
A total of 243 candidate interviewers took part in a
three-week training and evaluation course in Mtwara in
June 2007. Most of the trainees came from the study
districts and had 4 years of secondary education. They
were trained to seek written informed consent, list
members of the household, document household assets
and recent deaths in the family before completing birth
histories by direct questioning of women aged 13-49
years. Specific questions were asked about related issues,
such as birth preparedness and care of the newborn.
These are sensitive issues for most rural women and so
training aimed to prepare interviewers to ask the ques-
tions with authority, respect and understanding.
Training was led by IPTi project core staff, supported
by pre-trained, experienced field coordinators, and
invited experts in fields such as maternal health and
birth history studies. The training agenda included lec-
tures, group discussions, field practicals and feedback
sessions. During the course of training, potential team
supervisors and mappers (whose job it would be to list
and map all households in a sub-village) were identified
and subjected to an additional training course consisting
of management and quality control issues as well as
field tests. Interviewers, mappers and supervisors were
selected based on merit, and various techniques devel-
oped and used to assess performance during the course
of training.
Logistics and timing
The survey staff were split into 22 teams arranged into
four platoons, each led by a Commander (a senior,
experienced field supervisor). The Commander was
directly in charge of five or six survey teams, each con-
sisting of a supervisor, a mapper and seven interviewers.
Each platoon had a bus and two or three four-wheel
drive vehicles. The Commanders were responsible for
allocating each team to a sub-village and, between them,
ensuring that all sub-villages on the master list were
allocated to teams according to pre-determined criteria.
This ensured a balanced workload between teams and a
reasonable balance of teams working in each division to
minimize any potential bias.
The main survey started on 25 June and lasted 128
days, finishing on 30 October. A support unit rotated
between the platoons to ensure adequate supplies were
maintained and to collect completed consent forms and
backed-up data on CDs. These were all delivered to the
project office in Mtwara where focussed data cleaning
was performed before production of call lists for the
child health survey team.
Field methods-child health survey
A simple random sub-sample of eight vitongoji per divi-
sion (192 of the 2,621) was chosen for the child health
survey. In selected vitongoji, all households with a child
under 24 months, and whose mother had agreed in
principle in the main survey to be re-visited, were
approached for interview approximately 2 weeks after
the main survey. The child health module included
questions on IPTi and vaccine coverage, breastfeeding,
Vitamin A supplementation, case management and
care-seeking for any recent illness.
Twelve trainees were selected from the main survey
group and trained from 28 June 2007 to 7 July 2007.
The training comprised lectures, practical sessions, field
practice on taking blood samples and interviewing,
group discussions and feedback sessions. At the conclu-
sion of training two teams of four interviewers, a driver
and a supervisor started the survey itself. Call lists pro-
duced from the main survey data enabled identification
of individuals for interview. Where consent was pro-
vided, mothers of all children under 2 years were inter-
viewed. The availability of geo-coordinates from the
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main survey greatly enhanced the efficiency of this sub-
study, which was completed on 16 November 2007.
Quality assurance
In both the main survey and the child health survey,
several approaches to data quality assurance were used.
Each day of the survey, for every team, these included
random repeats and cross-checking of the mapping,
accompanying one interview by one of the team, revisit-
ing all households reported to be empty, and re-inter-
views repeating part of the questionnaire in a random
sample of four interviews. Data were compared with the
original interview and discrepancies discussed and
resolved.
Data management
Data were entered into PDAs at the time of collection,
using range, logical and internal consistency checks at
the time of data entry. At the end of each day a manual
summary of the day’s activities was produced and com-
pared with an electronic summary of the same informa-
tion. When discrepancies arose, for example as the
result of incorrect entry of a cluster or household num-
ber, the source of the discrepancy was identified and
recorded in a data error log sheet and in supervisors’
note books. These documents were used to guide clean-
ing of data in Access http://www.microsoft.com.
Statistical analysis
Statistical analysis was performed using STATA version
9 (College Station, Texas, USA), using an analytical plan
which was reviewed by the Data and Safety Monitoring
Board and agreed before the end of data collection.
Primary analysis
The primary analysis was based on a t-test of the (log)
mortality rates in infants aged two-11 months in IPTi
and comparison divisions, over the 2 year period
between 24 May 2005 and the date of the survey visit in
2007. This approach was used, rather than individual-
level regression modelling, partly because this is the
recommended approach for studies with fewer than 15-
20 clusters per treatment arm, and partly because there
was no individual level data [11].
Secondary analysis
Restricted randomization ensured balance at baseline in
infant survival, population size and district. Despite the
use of restricted randomization, with only 24 clusters it
was thought likely that the two groups would differ with
regard to contextual factors related to infant survival,
which would be potential confounders. For example,
there were mosquito net campaigns in some parts of the
area in 2005. As the use of treated nets is likely to be
associated with better child survival, imbalances in net
use would make this a potential confounder in the
analysis of the effect of IPTi. Other potential confoun-
ders of the effect of IPTi, either a priori or from pre-
vious analysis, include socio-economic status, distance
to the nearest health facility, maternal education, mater-
nal age, twinning, ethnic group, and care-seeking for
child illness. Baseline infant survival was also considered
a potential confounder, despite the relative balance at
baseline.
For each of these potential confounding factors direct
or proxy measures were taken from study data, using
the full survey where possible as this has the largest
sample size. For example, treated net use in individuals
is closely related to net ownership in households, but
will always be lower than household net ownership.
Data on net ownership was available from all 243,612
households visited, whereas data on use of treated nets
was available only in the subsample of 2,953 children
included in the child health survey (between 63 and 250
from each division). Household net ownership was used
as a proxy measure of treated net use in children,
because of the increased sample size with this approach.
Secondary analyses were planned to adjust for actual
confounders from the above list. Confounding was
investigated using Poisson regression analysis, and
planned to adjust for any factor that changed the impact
estimate by more than 15%. P-values for the adjusted
impact estimate were calculated using a t-test, compar-
ing the residuals (i.e. the ratio of observed and expected
deaths) in intervention and comparison divisions from a
model containing all confounders but not the effect of
IPTi.
Exploratory dose response analysis
Using simple graphical methods, an exploratory ecologi-
cal analysis of dose-response at division level was done.
The ‘dose’ of IPTi was estimated using division-by-divi-
sion coverage of IPTi by (1) the subsample of 1,731 chil-
dren aged 12-23 months from the 2007 household
survey and (2) routine EPI reports from each health
facility as a proxy for the dose of IPTi [A Bush et al.,
manuscript in preparation]. The ‘response’ to IPTi was
estimated through the division-by-division change in
mortality in infants aged two-11 months between 2001-
4 and 2005-7, using the 2004 and 2007 household sur-
veys respectively.
Ethical issues
The study was undertaken within the framework of the
assessment of the community effectiveness of IPTi, part
of the IPTi Consortium http://www.ipti-malaria.org. The
study had ethical approval from local and national insti-
tutional review boards (Ifakara Health Institute, formerly
Ifakara Health Research and Development Centre, Ifa-
kara, and the National Tanzania Medical Research Co-
coordinating Committee) through the Tanzania
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Commission for Science and Technology. Ethical and
research clearance was also obtained from the institu-
tional review board of the London School of Hygiene
and Tropical Medicine, UK, and from the Ethics Com-
mission of the Cantons of Basel-Stadt and Basel-Land,
Switzerland. The project team in Tanzania presented
the design, aims, objectives and updates of the pilot
IPTi implementation project to District Councillors,
who are elected representatives of the community, and
benefited from their support of the intervention and its
evaluation. During field work, information sheets in
Swahili about the study were given out, explaining why
it was being done, by whom, and what it would involve.
In the household survey, written consent of all house-
hold heads was sought. In addition, women aged 13-49
years were asked to give verbal consent before the birth
history interview. The trial is registered on clinical trials.
gov, number NCT00152204.
Results
Completeness of survey data
The 2007 survey identified 243,612 households in 2,621
vitongoji (sub-villages) (Table 1). The household head
was present in 227,789 (94%) and of these 99% agreed
to take part. A total population of 818,695 was recorded
in these households, with 213,233 women aged 13-49
years. Ninety-one percent of these women were inter-
viewed. Completeness of the information was similar to
the baseline survey in 2004.
For the subsample of households selected for the child
health survey, a total of 2,907 households identified in
the main survey as having children under 2 years were
visited. In these households, 3,024 children aged under
2 years were included, of whom 2,953 (98%) had infor-
mation on use of treated mosquito nets. Information on
sickness in the 2 weeks preceding the survey was avail-
able in 3,006 children, of whom 1,432 (48%) had been
ill. Of these, 40% (576/1432) had sought care from the
formal health sector, among whom 96% (547/576) had
information on care-seeking.
Comparability of intervention and comparison groups
Completeness and participation were similar in interven-
tion and comparison groups, with 94% of household
heads present and 99% agreeing to participate in both of
the two study arms (Table 2). The Makonde ethnic
group were more common in comparison divisions
(62%) than in intervention divisions (46%), but the dif-
ference did not reach statistical significance (P = 0.15,
comparing mean proportions in 12 intervention and 12
comparison divisions). The two groups were similar
with regard to socio-economic status, mosquito net
ownership, maternal education, maternal age, net use in
pregnancy, antenatal attendance, and home births.
Geographic data were incomplete for both groups due
to logistic problems when transferring GPS data to lap-
tops, but by chance a smaller proportion were missing
for the intervention group (23%) than for the compari-
son group (28%). For the subgroup with complete data,
28% of the intervention group lived within 5 km of the
nearest health facility, and 23% of the comparison group
(P = 0.19, comparing mean proportions in 12 interven-
tion and 12 comparison divisions).
For coverage and other child health indicators from the
sub-study, the two groups were similar with regard to
exclusive breastfeeding in infants aged nought to 5 months
and the use of mosquito nets. Care-seeking for a sick
infant from a formal health care provider was less com-
mon among the intervention group than the comparison
group (37% vs 43%, P = 0.04, comparing mean proportions
in 12 intervention and 12 comparison divisions).
Coverage of IPTi and corresponding vaccines (and
comparison with previous estimate, from 2006 surveys)
IPTi is given alongside DPT and measles vaccines, and
coverage of these vaccines was similar in IPTi and com-
parison areas (Table 3). DPT vaccine coverage was esti-
mated at 86% in both intervention and comparison
groups (P = 0.44) and measles vaccine coverage at 78%
in the intervention group and 80% in the comparison
group (P = 0.79).
Table 1 Study population and completeness of information, 2004 and 2007 surveys
Baseline survey (2004) Follow-up survey (2007)
Households visited 21,482/21,600 (99%) 243,612
Household head present 20,985/21,482 (98%) 227,789/243,612 (94%)
Household head agreed 20,894/20,985 (99.6%) 225,980/227,789 (99.2%)
Total population recorded 83,346 818,695
Women of reproductive age* 20,138 213,233
Women of reproductive aged interviewed 19,008 (94%) 193,848 (91%)
Mortality rate in infants 2-11 m (deaths/person-years) 36.2/1000 (217/59,936) 21.3/1000 (699/32,778)
Geometric mean of division-by-division mortality rate in infants 2-11 months 33.2/1000
95%CI: 27.2-40.4
Range: 12.4-81.1
22.1/1000
95%CI: 19.4-25.2
Range: 9.4-35.1
* 15-49 yr in baseline and 13-49 yr in follow-up survey.
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IPTi coverage was estimated in two different ways.
Using a conservative definition in children aged 12-23
months of three doses before 12 months of age, as
documented on the health card, IPTi coverage was 48%
in the intervention divisions and 2% in comparison divi-
sions (P <0.0001). Using a more lenient definition in
children aged 12-23 months of three doses either docu-
mented on the health card or reported by the mother,
Table 2 Context and comparability of intervention and comparison groups, 2007 survey
Intervention
divisions
n/N (%)
Comparison
divisions
n/N (%)
P*
Household head present 103,816/110,843
(94%)
123,973/132,769
(94%)
0.28
Household head agreed to participate 103,062/103,816
(99%)
122,918/123,973
(99%)
0.68
Ethnic group of household head Makonde 47,451 (46%) 76,644 (62%) 0.15 (Makonde vs
others)
Mwera 43,540 (42%) 26,844 (22%)
Makuwa 2,932 (3%) 8,278 (7%)
Yao 3,438 (3%) 4,922 (4%)
Other 5,701 (6%) 6,230 (5%)
Socio-economic status quintiles Poorest 20,893 (21%) 21,853 (19%) 0.39 (t-test on
means)
Very
poor
17,542 (18%) 20,698 (18%)
Poor 21,923 (22%) 24,852 (21%)
Less
poor
19,492 (20%) 23,816 (20%)
Least
poor
17,658 (18%) 25,428 (22%)
Lives over 5 km from health facility(23% missing in implementation divisions &
28% missing in comparison divisions)
23,882/85,276
(28%)
21,563/95,742
(23%)
0.19
Net ownership 67,228 (65%) 79,705 (65%) 0.81
Total population 375,399 443,184 0.56
Maternal education (≥ 1 y vs none) 66,233/88,747
(75%)
83,005/106,703
(78%)
0.88
Number (%) of women interviewed for birth history 88,215/97,076
(91%)
105,652/116,157
(91%)
0.54
Used treated net in pregnancy (treated in last 12 months) (for births in last year
only)
4,814/10,270
(47%)
5,824/11,980
(49%)
0.35
ANC attendance (for births in last year) 10,164/10,266
(99%)
11,894/11,977
(99%)
0.10
Age at interview (for births in last year) 13-19
years
20,068 (23%) 24,993 (23%) 0.79 (t-test on
means)
20-29
years
27,662 (31%) 33,463 (31%)
30-39
years
24,252 (27%) 28,919 (27%)
40-49
years
17,187 (19%) 19,786 (18%)
Born at home (for births in past year) 5,883/10,267
(57%)
6,741/11,975
(56%)
0.36
From Coverage and Malaria substudy:
Child aged 0-5 m is exclusively breastfed 13/223 (6%) 29/271 (11%) 0.19
Child 0-23 m sleeps under a mosquito net 697/1,311 (53%) 988/1,653 (60%) 0.38
Child 0-23 m sleeps under treated mosquito net 329/1,307 (25%) 520/1,646 (32%) 0.13
Sought care for sick baby from ‘western’ provider 234/634 (37%) 342/798 (43%) 0.04
# P-values are from t-test to compare mean proportions in 12 intervention & 12 comparison divisions unless marked otherwise
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coverage was estimated at 77% in intervention divisions
and 6% in comparison divisions (P <0.0001).
Mortality
There was a dramatic fall in overall mortality in both
intervention and comparison divisions between baseline
(2001-4) and the final survey (2005-7). The improve-
ment in survival was comparable in IPTi and compari-
son areas: rates in infants aged two-11 months fell from
34.1 to 23.6 per 1,000 person-years in intervention areas
and from 32.3 to 20.7 in comparison areas (Figure 2).
In 2005-7, divisions implementing IPTi had a 14%
(95% CI -12%, 49%) higher mortality rate in two-11
month olds in comparison with non-implementing divi-
sions. The difference was not statistically significant (P
= 0.31) (Table 4). There was no evidence of
confounding.
Dose-response analysis
The mortality rate change in the 12 implementing divi-
sions was plotted against the coverage of IPTi as
estimated by the 2007 survey. There was no evidence of
an association between coverage of IPTi at the division
level and survival of children aged two-11 months (Fig-
ure 3).
Discussion
To the best of our knowledge, this is the first study to
have attempted to estimate the effect of IPTi on infant
survival. Despite the large scale, the findings are compa-
tible both with a reduction and an increase in mortality
associated with IPTi. This may reflect a true lack of
effect of IPTi on survival, or the findings may be a false
negative result.
A number of design issues need to be considered
when considering these results. The most dramatic find-
ing was the marked improvement in survival between
2004 and 2007. In this period, mortality dropped by
about one third in both intervention and comparison
arms, causing a reduction in the power of the study to
find a statistically significant difference between the
group. However power also depends on the variability in
Table 3 Coverage of IPTi and corresponding vaccines, 2007 survey
Intervention divisions
n/N (%)
Comparison divisions
n/N (%)
P
Child 12-23 months documented to have received 3 doses of DPT vaccine 661/769 (86%) 823/962 (86%) 0.44
Child 12-23 months documented to have received measles vaccine 600/769 (78%) 766/962 (80%) 0.79
Child 12-23 months documented to have received doses 1 & 2 of IPTi 426/769 (55%) 27/962 (3%) < 0.0001
Child 12-23 months documented to have received all 3 doses of IPTi 371/769 (48%) 24/962 (2%) < 0.0001
Child 12-23 months reported or documented to have received doses 1 & 2 of IPTi 522/633 (82%) 104/770 (14%) < 0.0001
Child 12-23 months reported or documented to have received all 3 doses of IPTi 399/517 (77%) 43/709 (6%) < 0.0001
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Figure 2 Mortality in infants aged two-11 months.
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mortality rates between clusters, and this was also lower
than anticipated. Based on the 2007 results, the study
had over 80% power to find a 30% difference between
the groups as statistically significant, but under 20%
power to find a difference of 12% as statistically signifi-
cant at the 5% level, with 12% being the upper end of
the 95% confidence interval for the effect of IPTi on
survival found in this study.
A second methodological challenge arises from the
relatively small number (24) of intervention and com-
parison units. Despite the overall rapid change in survi-
val, mortality rates may not change at the same pace
everywhere, and there is a need to balance the rate of
change between intervention and comparison areas. The
best way to achieve this would be to increase the num-
ber of intervention units. The chosen unit was the divi-
sion, a sub-district administrative area, which is
reflected in the organization of health services. Operat-
ing at this level reflected a compromise between the
need to work with functional units of the health system
with the need for replication of intervention and com-
parison units. The study was designed with the primary
aim of assessing the feasibility of deploying IPTi: could
the IPTi strategy be successfully implemented through
the existing public health system in an under-resourced
part of a poor country? With minimal inputs from the
research team, could IPTi coverage reach or even exceed
that of the corresponding EPI vaccines? The estimate of
mortality impact was a secondary aim and, despite
restriction of randomization at baseline to ensure bal-
ance in terms of infant mortality, population size and
district location, it is possible that unmeasured-and so
far unknown to the study team-but important influences
on survival were not balanced between arms. Although
Table 4 Survival impact: mortality in infants aged 2-11 months, 2004 and 2007 surveys
Intervention Divisions
(n = 12)
Comparison Divisions
(n = 12)
Ratio
(95% CI)
P
2001-2004
(Baseline)
Mortality rate per 1000 person-years: geometric mean* (95% CI) 34.1 (26.4-44.0) 32.3 (22.9-45.5) 1.06
Number of deaths 111 106
2004-2007
(Follow-up)
Mortality rate per 1000 person-years: geometric mean* (95% CI) 23.6 (20.0-27.9) 20.7 (16.5-26.0) 1.14
(0.88, 1.49)
0.31
Number of deaths 340 359
*Geometric mean of the 12 division-specific rates
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there was an imbalance between the arms with regard to
the completeness of geographic data, this imbalance
seems unlikely to affect the conclusions of the study,
Is it possible that IPTi did not improve survival in
southern Tanzania? The current study included house-
hold surveys in 2006 which suggested a modest impact
of IPTi on malaria parasitaemia (from 38% to 31%, p =
0.06) and anaemia (from 88% to 80%, p = 0.02), despite
coverage which was lower than anticipated [8]. Morbid-
ity monitoring of malaria in 11 sentinel health facilities
suggested that IPTi was associated with a reduction in
clinical malaria of between 18% and 54%, depending on
the scope of the analysis, although no differences
reached statistical significance [9]. A recent pooled ana-
lysis of the efficacy of IPTi in six individually rando-
mized studies in infants from Tanzania, Mozambique,
Ghana and Gabon concluded that IPTi prevented 30%
of clinical malaria episodes (95% CI 20-39) and 23% of
all-cause hospital admissions (95%CI 10-34) [1]. In addi-
tion, other malaria control tools are associated with a
larger impact on survival that can be explained by direct
malaria deaths alone [15,16]. Given this, it seems unli-
kely with current knowledge that IPTi has no impact on
infant survival, despite the null estimate of effect. Short-
term efficacy of IPTi-SP has been documented in a
seventh randomized controlled trial of IPTi-SP, pub-
lished at the same time as the pooled analysis, and con-
ducted in a part of northern Tanzania with very high
levels of resistance to SP. Although there was no overall
efficacy of IPTi in this setting, there was good evidence
of protection in the month following IPTi doses [17].
Resistance was rising during the time of our pilot imple-
mentation and it is possible that this undermined the
effect of IPTi.
The coverage of IPTi was lower than expected and
may not have been sufficient to result in a measurable
impact on mortality. Based on the results from the
phase-III studies [1], the authors consider it likely that
at least two timely doses of IPTi are needed in order to
have an impact on mortality. Coverage of two doses,
using both the information recorded on child health
cards and from asking the mother or guardian, was 82%
(95% CI 76-88%) in the intervention group and 14%
(95% CI 9-19%) in the comparison group. Using a more
conservative approach of three doses written on the
health card, and assuming children without a health
card had not received IPTi, coverage was 48% (95% CI
40-56%) and 2% (95% CI 0-6%) in the comparison
group. Leakage–whereby comparison group children
received IPTi–therefore appears to have been minimal.
However, there were considerable ‘missed opportunities’
for IPTi, where children received DPT or measles vac-
cines but not IPTi. This was due to a combination of
reasons such as a reluctance of some health staff to
offer IPTi, stock outs of SP, DTP or measles vaccines,
and recent history of treatment with SP, rather than
lack of acceptability to mothers and families [5,8]. In
addition there is evidence from qualitative work that
some health cards were falsely completed, both for vac-
cines and for IPTi [18]. If less than half of eligible chil-
dren received a sufficient dose of IPTi, and those who
did receive the intervention were at least risk of malaria,
it is possible that coverage was simply too low for any
impact on survival to have been measurable in the given
evaluation.
There was a marked reduction in the prevalence of P.
falciparum infection in the study area during the pro-
ject. Parasite prevalence in infants aged two-11 months
in the comparison areas (without IPTi) dropped from
57% to 38% between 2004 and 2006, and to 19% in
2007. The predominant reasons are the subject of
ongoing analysis but treated net use in infants aged
two-11 months in the comparison areas increased from
11% to 38% over the same time frame. Individual analy-
sis of risk factors for death in infants suggests that the
single biggest reason for the rapid drop in mortality was
this rise in the use of mosquito nets (unpublished obser-
vations). Furthermore, the first-line treatment for
malaria changed in 2006 from SP to artmether-lumfan-
trine (ALu). To the best of the study team’s knowledge
there were no other major malaria prevention or treat-
ment programmes ongoing in the area. The increase in
net use and the change of first-line drug may have
reduced malaria transmission to such low levels that
IPTi had no effect. However, this seems unlikely as the
individually randomized studies of IPTi were done in
settings where incidence rates of malaria ranges from
0.16 to 1.27 episodes per child per year and net use var-
ied from 0% to 67% yet notable protective efficacy was
described in these studies [11].
IPTi has recently been recommended by WHO as a
new malaria control tool for use in settings with moder-
ate to high malaria transmission and where the fre-
quency of the DHPS 540, a marker of the quintuple
mutation, is less than 50%. The evidence showing a ben-
efit of IPTi in such settings is overwhelming, and much
stronger than for many routinely implemented interven-
tions. The results of the current study were considered
as part of the WHO policy review process: the metho-
dological limitations of the study were recognized, but
the feasibility of IPTi implementation with available
resources confirmed.
At the start of this study a model of impact was out-
lined, showing the steps that were thought would lead
to mortality impact in this effectiveness setting (Figure
4). Firstly, trained health workers and IPTi should be
available in health facilities; secondly these should be
offered to children attending for EPI vaccines; and
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thirdly a high proportion of mothers should bring their
children for EPI vaccines. Data from our 2006 health
facility and household surveys suggest that the first and
third steps were reasonably well assured, but that
roughly one-third of children attending for EPI vaccines
were not offered IPTi due to demand and supply side
barriers, all of which had potential to be addressed
[8,18]. The fourth step was that IPTi would be well
accepted, and the data suggest that this was indeed the
case [5]. The fifth step was that there should be low
resistance to SP. Although in vivo efficacy was similar at
the outset to that seen in settings where IPTi had pre-
viously been shown to be efficacious, resistance
increased during the project, with the frequency of the
540E mutation at 68% in 2007. There are few data
points from other studies in higher resistance settings.
In an area with a background frequency of 56% for this
mutation [19], IPTi provided 21% protective efficacy
against clinical malaria [20], whereas no measurable pro-
tection against malaria was conferred by SP in an area
where the 540E mutation frequency was 90% [21].
The last step in the model was that there should be
some evidence of reduced malaria morbidity, which was
indeed the case in the study [8,9]. Taking all these ele-
ments together, it seems likely that a combination of (i)
lack of power combined with (ii) suboptimal coverage
and (iii) increasing levels of drug resistance undermined
this attempt to estimate the impact of IPTi on child
survival.
Conclusions
The findings of this large-scale randomized controlled
study are compatible both with a reduction and an
increase in mortality associated with IPTi. The lack of
evidence of an effect of IPTi on survival could be a false
negative result due to a lack of power or imbalance of
unmeasured confounders. Alternatively, there could be
no mortality impact of IPTi due to low coverage, late
administration, drug resistance, decreased malaria
transmission or improvements in vector control and
case management.
A cluster-randomized trial design was chosen in order
to estimate the impact of the intervention under condi-
tions that were close to ‘real-life’ in a large rural area
with a population of almost one million people. This
choice meant randomizing a relatively small number of
clusters, collecting ecological rather than individual data
on IPTi use, and evaluating impact with coverage rather
lower than had been hoped. The implications of the
findings for future large-scale impact evaluations are
sobering: despite a ‘probability’ design it is not possible
to draw a firm conclusion about the impact of IPTi on
infant survival. Another recent large-scale impact eva-
luation faced similar issues [22]. Evidence of the impact
on mortality of interventions, as deployed in real life, is
likely to require a different type of inference from that
used in individually randomized controlled trials. Inter-
vention-and context-specific models of impact need to
be developed before systematic, prospective collection of
quantitative and qualitative data enables a thorough pro-
cess evaluation as an integral part of the evaluation. The
plausibility, rather than the probability, that a change in
survival is the result of the intervention can then be
assessed.
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